Rochester Clinical Research is enrolling adults ages 50 to 64 for a vaccine research study focused on helping prevent C. diff infection.
If you are generally healthy and interested in participating in medical research, you may qualify.
C. diff Prevention
Age Range:
50 to 60
Gender:
Male and Female
Location:
Rochester, New York
About the Study
This study is testing an investigational vaccine designed to help protect against Clostridioides difficile (C. diff), a bacteria that can cause severe diarrhea and intestinal illness.
Qualifications
You may qualify if you:
- Are 50 to 64 years old
- Are generally healthy
- Are not currently diagnosed with C. diff infection
Additional eligibility criteria will be reviewed by the study team.
FEATURED STUDIES
Rochester Clinical Research is enrolling adults ages 50 to 64 for a vaccine research study focused on helping prevent C. […]
Rochester Clinical Research (RCR) is enrolling volunteers for a research study testing an investigational pneumococcal vaccine. This study is looking […]
Rochester Clinical Research in Buffalo is conducting a research study focused on Lyme disease prevention.
Rochester Clinical Research is currently enrolling adults in a new smoking cessation research study. This trial is designed to evaluate […]
Rochester Clinical Research is taking part in a new study evaluating an updated COVID-19 vaccine for generally healthy patients ages […]
Rochester Clinical Research is currently enrolling adults 18 years and older for a research study to learn if a series […]